Clin Transl Oncol 2020 Jan 31
SEOM clinical guideline for secondary prevention (2019).
Santaballa A, Pinto Á, Balanyà RP, Ramírez Merino N, Martín IR, Grau SS, Fombella JPB, Cano JM, González CH, Bayo J
Cancer is one of the major public health problems in our society. It is estimated that more than 18 million new cases are diagnosed worldwide every ye ...
Read More
Source: PubMed
Urology 2020 Jan 28
Outcomes and Complications after Intervention for Post-Radiation Prostatic Urethral Stenosis.
Smith SM, Han JS
To study and report on treatment outcomes after surgical intervention for post-radiation prostatic urethral stenosis. ...
Read More
Source: PubMed
Clin. Chim. Acta
Advances in prostate specific antigen biosensors-impact of nanotechnology.
Negahdary M, Sattarahmady N, Heli H
Prostate cancer is one of the most dangerous and deadly cancers in elderly men. Early diagnosis using prostate-specific antigen (PSA) facilitates dise ...
Read More
Source: PubMed
J Nutr Health Aging
HoSAGE: Sarcopenia in Older Patients before and after Treatment with Androgen Deprivation Therapy and Radiotherapy for Prostate Cancer.
Couderc AL, Muracciole X, Nouguerede E, Rey D, Schneider S, Champsaur P, Lechevallier E, Lalys L, Villani P
Sarcopenia is a muscle disease defined by a loss of muscle strength associated to a decrease in skeletal muscle mass. In addition to aging, many facto ...
Read More
Source: PubMed
Cancer Control
Geographic-Level Association of Contemporary Changes in Localized and Metastatic Prostate Cancer Incidence in the Era of Decreasing PSA Screening.
Yang DX, Makarov DV, Gross CP, Yu JB
Decreased prostate-specific antigen screening since 2008 has generated much concern, including report of recent increase in metastatic prostate cancer ...
Read More
Source: PubMed